ZimVie Inc. (NASDAQ:ZIMV) Q1 2024 Earnings Call Transcript

Vafa Jamali: Yes. Undoubtedly, if procedures slow down, those purchases will be somewhat reduced. But we’re seeing close to 50% growth of the guided surgery line, and that’s no capital allocation for the customer. They’re buying as they go. So, we’re seeing great, great adoption there. And we’re getting a very, very high renewal rate for that subscription. So, we think that all of the elements point to a pretty good recovery for us. Once the end market returns, I think we’re going to have more customers. And like I said, we’re pulling through our implants on that. So, I’m feeling pretty confident that we’ve got the right portfolio.

Matt Miksic: Great. Thanks so much for the color.

Vafa Jamali: Thanks Matt. Talk to you soon.

Operator: Thank you for your participation in today’s conference. This does conclude the program. You may now disconnect.

Vafa Jamali: Thank you.